Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews (Q43986807)

28 November 2017

Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews (English)

1 reference

28 November 2017

0 references

1 reference

9

Jaqueline Sulkes

1 reference

28 November 2017

Baruch Brenner

1

1 reference

28 November 2017

Georgeta Fried

2

1 reference

28 November 2017

Pavel Levitzki

3

1 reference

28 November 2017

Erica Rakowsky

4

1 reference

28 November 2017

Hedwig Lurie

5

1 reference

28 November 2017

Efraim Idelevich

6

1 reference

28 November 2017

Avivit Neuman

7

1 reference

28 November 2017

Bella Kaufman

8

1 reference

28 November 2017

Aaron Sulkes

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

94

1 reference

28 November 2017

8

1 reference

28 November 2017

2128-2133

1 reference

Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Founder BRCA1/2 mutations among male patients with breast cancer in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Carcinoma of the breast in males: a multiinstitutional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Male breast carcinoma. II. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to treatment, prognostic factors and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Localized male breast carcinoma and family history. An analysis of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

A comparison outcome of male breast cancer with female breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Prognosis of breast cancer in males: an analysis of 170 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10449

21 January 2018

Identifiers

DOI

10.1002/CNCR.10449

1 reference

28 November 2017

1 reference